novo nordisk news - Search News

Novo Nordisk, obesity and Health Canada

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults, the Danish drugmaker said on Wednesday.

Pharmaceutical Technology · 4h

Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).

cbc.ca on MSN · 18h

Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

Global News · 1d

Wegovy approved in Canada to combat risk of non fatal-heart attack

Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

obesity, Joe Biden and Novo Nordisk

Investopedia on MSN · 1d

Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs

Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' popular weight-loss drugs in government-backed healthcare plans including Medicare and Medicaid.

Reuters on MSN · 2d

Novo Nordisk shares rise as Biden proposes obesity care coverage

COPENHAGEN (Reuters) -Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid.

ABC News on MSN · 1d

Biden proposes expanding obesity drug coverage under Medicare and Medicaid

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.

1don MSN

Novo Nordisk Is Scaling Back Its Hiring Spree in Denmark

Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...

Wall Street Journal on MSN1d

Novo Nordisk Says White House Obesity Plan Is Step in Right Direction

Novo Nordisk is encouraged by White House proposals that could support patients using weight-loss drugs, but cautioned ...

Bloomberg L.P.2d

Novo Nordisk Foundation Targets US, Europe After Obesity Boost

The world’s largest philanthropic fund that ultimately controls Novo Nordisk A/S will ramp up its investments outside of ...

1d

Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

3d

Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?

Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the ...

8don MSN

Is Novo Nordisk Stock a Buy Right Now?

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China ...

2d

Novo Nordisk: Supply Strains, Competition, And RFK Concerns Mask Solid Fundamentals

Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results